In the present study, acetate-protected monogalactosyldiacylglycerol and its fatty acid and aromatic acid analogues were synthesized using trichloroacetimidate methodology. All compounds synthesized were evaluated for cytotoxicity against four cancer cell lines and one normal cell line. Among the compounds tested, mixed acid compound 7b exhibited good activity with IC 50 value of 27.5 μM. In a similar manner, the combination of unsaturated oleic acid and cinnamic acid compound 7d also exhibited significant activity with IC 50 value 34.9 μM. Based on these results, it could be concluded that the combination of oleic acid with cinnamic acid type acid and other saturated fatty acids enhance the cytotoxicity of glycoglycerolipids.
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derivatives with aromatic acids (with saturated side chain). These reports demonstrated that the presence of aromatic groups have a negative impact on activity whereas unsaturated and conjugated fatty acids showed a positive impact [20] . However, all the reported aromatic acids were not the cinnamic acids with unsaturated side chain. Based on this key observation, it was speculated that the glycoglycerolipids with the combination of cinnamic acids and unsaturated fatty acids might exhibit good cytotoxicity. Moreover, in 1989, Yoshihiro et al. isolated [23] an unusual cinnamic acid containing glycoglycerolipid from Liliumauratum var platyphyllum ( fig. 1) . Hence, in the present study an attempt has been made to synthesize and evaluate the cytotoxicity of acetate-protected monogalactosyldiacylglycerols having aromatic acids as well as unusual fatty acids.
MATERIALS AND METHODS
All the chemicals used in this investigation were of analytical grade, were obtained from different commercial sources and were used without any further Glycoglycerolipids are important molecules from a cancer chemoprevention perspective due to their promising inhibitory effect on tumour growth. They are major constituents present in chloroplast membranes of photosynthetic cells and in bacterial cell walls [1] [2] [3] . Various glycoglycerolipid types were earlier isolated from different sources like bacteria [4] , algae [5] and plants [6] . The fatty acyl chain length, its position, and the nature of the sugar moiety are some of the important features that influence cytotoxicity [7, 8] . Glycoglycerolipids have gained significant attention in view of their diverse properties such as antitumor [4] [5] [6] [9] [10] [11] , antimicrobial [12] , antiviral [13, 14] , antiinflammatory [15] , immunosuppressive [16] and oxygen scavenging [17] activities. However, all these activities are strictly dependent on their fatty acyl chain length [18, 19] and olefinic nature [13] . These types of glycolipids effectively inhibited the cell proliferation and induce apoptosis in cancer cells via an intrinsic pathway by activating caspase 3 and 9 [20] . Moreover, recent research on glycolipids demonstrated that these are functional molecules involved in a number of cellular physiological pathways, which provided a novel area of targets for cancer immunotherapy [21] . This finding led to the development of a number of vaccines that are showing promising results in recent clinical trials. A few reports [22] were published on synthesis and antitumor activity of glycoglycerolipids purification. All dry reactions were carried out under nitrogen atmosphere using anhydrous freshly distilled solvents and 4 Å molecular sieves in flame-dried glassware using standard gas-light syringes, cannulae and septa. Reactions were monitored on micro thin-layer chromatography plates coated with TLC grade silica gel (Merck) and the spots were detected under iodine vapours. Column chromatography was performed using silica gel (100-200 mesh) procured from Qualigens (India) using freshly distilled solvents. All the 1 H-nuclear magnetic resonance (NMR) and 13 C-NMR spectra were recorded on a Bruker Avance (operated for 1 H-NMR at 300 MHz, 500 MHz and for 13 C-NMR at 75, and 125 MHz) spectrometer, using TMS (δ=0 ppm) and δ 77.00 parts per million (ppm) as internal standard for chemical shifts (δ) in CDCl 3 at 25°. The chemical shift values are presented in ppm units. Mass spectra were recorded on a high-resolution electrospray ionisation mass spectrometry (HR-ESI-MS). Infrared spectra were recorded in chloroform (CHCl 3 ) on a Perkin-Elmer FT-IR spectrum BX. The melting points were determined on a Barnstead Electro Thermal 9200 instrument.
1,2,3,4,6-Penta-O-acetyl-β-D-galactopyranoside (1):
A mixture of galactose (2 g, 11.108 mmol) and sodium acetate (2.73 g, 33.31 mmol) were dissolved in acetic anhydride (17.5 ml, 187 mmol). The reaction mixture was refluxed for 4 h at 90°. After reaction time, the reaction mixture was cooled to room temperature and then poured into the beaker containing crushed ice (150 ml) under stirring conditions. The penta-acetate was precipitated. The precipitation was filtered and washed with ice-cold water until the odour of the acetic acid was disappeared. The crude product was purified by recrystallization from MeOH to afford the title compound (3.98 
-tetra-Oacetyl-galactopyranosyl)-sn-glycerol (4):
Imidate (3, 3 g, 6.09 mmol), 1,2-isopropylidene glycerol (1.2 g, 9.14 mmol) and 4 A° molecular sieves were dissolved in freshly distilled DCM (35 ml). To this reaction mixture trimethylsilyl trifluoromethanesulfonate (TMSOTf; 0.32 ml, 1.82 mmol) was added dropwise at 0° and the reaction mixture was slowly allowed to room temperature and stirred for overnight. After utilizing all the starting materials, the reaction mixture was filtered and dissolved in EtOAc and water. The organic layer was extracted with aqueous sodium bicarbonate (NaHCO 3 ) solution, dried over anhydrous Na 2 SO 4 and concentrated under reduced pressure. The crude mixture was purified by silica gel column chromatography. The required spot was eluted in hexane:EtOAc (3:1, v/v) solvent mixture as a white solid (2.3 g, 82 %). 
' -tetra-O-acetylgalactopyranosyl)-sn-glycerol (4, 2 g, 4.32 mmol) was dissolved in acetonitrile (25 ml) and 5 equivalents zinc nitrate hexahydrate (6.43 g, 21.63 mmol) was added, the reaction mixture was stirred for 6 h at 50°. After completion of reaction, the starting materials and the organic solvent was evaporated under reduced pressure and the mixture was portioned in water and CHCl 3 . The organic phase was dried over anhydrous Na 2 SO 4 and evaporated. The crude reaction mixture was purified by silica gel column chromatography using hexane:EtOAc (5:1, v/v) solvent mixture to give solid (1.36 g, 75 %). 
' -tetra-O-acetyl-galactopyranosyl)-sn-glycerol (5, 1 mol) was dissolved in anhydrous DCM (10 ml), fatty acid (2 mol), N-(3-dimethylaminopropyl)-N′ethylcarbodiimide hydrochloride (EDC; 2 mol) and 4-dimethylaminopyridine (DMAP; catalytic amount) were added under nitrogen at 0°. The reaction mixture was stirred for overnight at room temperature. After all the starting materials have been used, the reaction mixture was dissolved in CHCl 3 and washed with water and brine solution. The organic layer was dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure. The mixture was purified by silica gel column chromatography using hexane:EtOAc (4: 1, v/v) solvent mixture to give title compounds (6a-6f) in 88-92 % yields. 
1,2-O-Di-butanoyl-3-O-(β-
D(500 MHz, CDCl 3 ): δ 5.38 (m, 1H), 5.22-5.17 (m, 2H), 5.02-4.99 (m, 1H), 4.49 (t, J=8.39 Hz, 1H), 4.32-4.30 (
1,2-O-Di-cinnamoyl-3-O-(β-D-2 ' ,3 ' ,4 ' ,6 ' -tetra-Oacetyl-galactopyranosyl)-sn-glycerols (6f):
The title compound was obtained in hexane:EtOAc 
' -tetra-O-acetyl-galactopyranosyl)-sn-glycerol (5, 1 mol) was dissolved in anhydrous DCM (10 ml), oleic acid (1 mol), EDC (1 mol) and DMAP (pinch) were added under nitrogen at 0°. The reaction mixture was stirred for 6 h at 0°. After utilizing starting materials, equimolar amounts of fatty acid, EDC and a little amount of DMAP were added subsequently. The reaction mixture was stirred at room temperature for overnight. Then the reaction mixture was dissolved in CHCl 3 and washed with water and brine solution. The organic layer was dried over anhydrous Na 2 SO 4 and evaporated under reduced pressure. The mixture was purified by silica gel column chromatography using a solvent mixture of hexane:EtOAc (4:1, v/v) to give title compounds with 86-92 % yield. Oleoyl-2-O-octanoyl-3-O-(β-D- 
1-O-

1-O-Oleoyl-2-O-valiproyl-3-O-(β-D-2 ' ,3 ' ,4 ' ,6 ' -tetra-O-acetyl-galactopyranosyl)-sn-glycerols (7b):
The title compound was obtained in hexane:EtOAc (4:1, v/v) solvent mixture with 92 % yield. Oleoyl-2-O-10-undecenoyl-3-O-(β-D-2 ' ,3 ' ,4 ' ,6 ' -tetra-O-acetyl-galactopyranosyl)-sn-glycerols (7c):
1-O-
The title compound was obtained in hexane:EtOAc (4:1, v/v) solvent mixture with 90 % yield. 07 (m, 3H), 3.97-3.88 (m, 2H), 3.70-3.65 (m, 1H) 
1-O-Oleoyl-2-O-cinnamoyl-3-O-(β-D-2 ' ,3 ' ,4 ' ,6 ' -tetra-O-acetyl-galactopyranosyl)-sn-glycerols (7d):
The title compound was obtained in hexane:EtOAc (4:1, v/v) solvent mixture with 88 % yield. 
1,2-Isopropylideneglycerol (8):
Glycerol (3 g, 30 mmol), 2,2-dimethoxy propane (45 mmol, 4.6 g), dry acetone (30 ml) and a catalytic amount of para-toluenesulfonic acid (10 mg) were stirred at room temperature for 24 h. After the reaction time, acetone and unreacted 2,2-dimethoxy propane was evaporated under reduced pressure. The reaction mixture was purified by silica gel column chromatography using solvent mixture EtOAc:hexane (40:60; v/v) the compound was isolated as colourless oil with 70 % (3.01 g) yield. 
Cytotoxicity using MTT assay:
Cytotoxicity assay (MTT) was evaluated for the test compounds 6a-6f and 7a-7d as reported earlier [24] . Four different cancer cell lines and one normal cell line namely, SKOV3-ovarian cancer (ATCC ® HTB 77™), HeLa-cervical cancer (ATCC ® CCL 2™), MDA-MB-231-breast cancer (ATCC ® HTB 26™), DU145-prostate cancer (ATCC ® HTB 81™) and CHO-K1-normal Chinese hamster ovary cell line (ATCC ® CCL-61™) were obtained from the ATCC (Bethesda, MD, USA) and maintained in Dulbecco's modified Eagle's medium supplemented with 10 % fetal bovine serum, 2 mM l-glutamine, 100 U/ml penicillin, and 100 μg/ml streptomycin at 37° in a 5 % CO 2 incubator. After seeding of cells in 96 well culture plate, allowed to attach properly. Test compounds of different concentrations ranging from 1 to 50 µM were added in triplicates and incubated for 24 h. The cells were then incubated with MTT (0.5 mg/ml) for 3 h and to dissolve the insoluble formazan crystals 100 µl DMSO was added to each well. Finally, the absorbance of the plates was measured using a Synergy H1 multi-mode plate reader, USA. Doxorubicin was used as positive control for the comparison.
RESULTS AND DISCUSSION
These molecules were synthesized employing earlier reported methods [20] . As depicted in the fig. 2 , the synthesis of galactosyldiacylglycerols started with acylation of galactose with Ac 2 O and NaOAc under reflux conditions for 4 h. The anomeric acetate group was chemoselectively removed by hydrazine acetate. Subsequently, hemiacetal 2 was reacted with trichloroacetonitrile in the presence of DBU and exclusively formed α-trichloroacetimidate 3 due to anomeric effect. The coupling of imidate 3 with 1,2-isopropylidene glycerol 8 (which was obtained from glycerol as shown in fig. 3 fatty acid (1 eq.), 0°, 6 h, fatty acid (1 eq.) , room temperature, overnight, 88-92 % 82 % yield. This β-orientation was achieved by NGP of C-2ʹ acetate group of sugar with C-1ʹ carbon of sugar as it allowed only equatorial attack of acceptor. 1H-NMR analysis revealed that the signals of H-1ʹ proton was observed as dd at δ=4.56 ppm, J=7.94, 10.63 Hz. Diol 5 was obtained through selective hydrolysis of isopropylidene group of 4 by zinc nitrate hexahydrate in acetonitrile [21] . Mixture of fatty acid analogues 7(ad) were synthesized using the following procedure, the diol 5 was selectively esterified at C-3 OH of glycerol with oleic acid (1 mol) by using EDC-HCl (1 eq.) and DMAP (cat.) at 0° for 6 h reaction period. At the same time to avoid the acyl migration of fatty acid from C-3 OH to C-2 OH of glycerol, simultaneously another fatty acid, EDC-HCl and DMAP were added in equimolar ratio to the same reaction mixture and stirred for overnight at room temperature to give mixture of fatty acid analogues 7(a-d) with 89-92 % yield. Under these experimental conditions, 2-acyl glycerol derivative was not observed in the reaction mixture. For the synthesis of other fatty acid analogues (6a-6f), EDC-HCl was used at room temperature for overnight to get 88-92 % yields.
All the synthesized glycoglycerolipids were examined for cytotoxicity against four cancer cell lines and one normal cell line namely, SKOV3, HeLa, MDA-MB-231, DU145 and CHO-K1 cell lines. The results are tabulated in Table 1 . All the tested compounds exhibited moderate to significant cytotoxicity against HeLa, MDA-MB-231 cancer cell lines with IC 50 values between the 27.5-117.0 µM ranges. Among all the tested compounds, in mono acid glycoglycerolipids compound 6c (C11:1) and 6b (C6:0) exhibited significant activity with IC 50 values 30.3 and 41.4 μM, respectively. Whereas, in mixed acid glycoglycerolipids case the compound 7b exhibited good activity with IC 50 values 27.5 μM due to the balancing combination of active fatty acids such as branching valproic acid and unsaturated oleic acid. In similar manner the combination of unsaturated oleic acid and cinnamic acid compound 7d also exhibited significant activity with IC 50 values 34.9 μM. All other compounds exhibited the moderate to poor activity against HeLa and MDA-MB-231 cell lines. Moreover, all the tested compounds didn't show any toxicity towards normal CHO-K1 cell line.
In conclusion, in this investigation unusual fatty acid and aromatic acid (cinnamic acid)-based, acetate-protected monogalactosyldiacylglycerol were synthesized employing trichloroacetimidate methodology. All the synthesized glycoglycerolipids were examined for cytotoxicity against four cancer cell lines and one normal cell line. Based on the results, it could be concluded that the combination of oleic acid with aromatic acid (cinnamic acid type) and other saturated fatty acids enhances the cytotoxicity of glycoglycerolipids. -PROTECTED GLYCOGLYCEROLIPIDS (6a-6f, 7a-7d 
